7 ML amivantamab-vmjw 50 MG/ML Injection [Rybrevant]
NO BLACK BOX WARNING
Dosage & administration
Body Weight (at Baseline)
Recommended Dose
Less than 80 kg
1050 mg (3 vials)
Greater than or equal to 80 kg
1400 mg (4 vials)
eficacy, safety & testing
Rybrevant clinical details
Mechanism of Action (MOA)
EGFR Exon 20 Insertion Mutations Testing
Efficacy
Safety Profile
Dosing & Administration
drug label
Rybrevant prescribing information
Have more Rybrevant questions?
Submit MSL Request
Learn More
Your request will be referred to the appropriate Janssen Biotech, Inc. medical professional, such as a Rybrevant pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report a Rybrevant issue?
ONLINE FORMReport adverse event
Learn More
You can report a Rybrevant adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
prior authorization
Rybrevant Prior authorization resources
Complete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
NOT PROVIDED BY BRANDCoverage Authorization Appeals
Letter of Exception
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
Rybrevant Benefits Investigation Form
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
NOT PROVIDED BY BRANDReimbursement help (FRM) resources
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Rybrevant Financial assistance options
Co-pay savings program
commercial only
Rybrevant Benefits Investigation Form
Enroll in Patient Savings Program
Learn More
Overview
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Learn More
Overview
Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
100% free (outside of insurance)
Patient eligibility
HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
J&J Patient Assistance Program - Eligibility Check
Learn More
Overview
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Rybrevant Patient education
Getting started on Rybrevant
NOT PROVIDED BY BRANDInstructions For Use: Metastatic NSCLC with EGFR Exon 20 Insertion Mutations
Patient toolkit
Patient Brochure
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Rybrevant Savings Program Overview
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Rybrevant
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Side Effects
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Receiving Rybrevant
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
people also ask
Rybrevant FAQs
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
Can't find what you're looking for?
Our trained staff can help you:
Please note:
Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.
